Aclaris Therapeutics Inc (ACRS)

Aclaris Therapeutics Inc (ACRS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $483M; returns 1 day -2.1%, 1 week +14.3%, 1 year +65.9%.

Aclaris Therapeutics, Inc. (ACRS) is a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases. Aclaris is currently focused on advancing its clinical programs with the goal of improving therapeutic options for patients with certain immuno-inflammatory (I&I) diseases.

Groups ACRS belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Healthcare
• Autoimmune Diseases
• Chronic Inflammatory Diseases
• Bispecific Antibodies
• Clinical Stage
• Dermatology
• Immunotherapy
• Antibody Therapeutics

ACRS financial model: income statement, cash flow and balance sheet